403 related articles for article (PubMed ID: 10672058)
1. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
2. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
4. Expression of cutaneous lymphocyte-associated antigen and TIA-1 by lymphocytes in pityriasis lichenoides et varioliformis acuta and lymphomatoid papulosis: immunohistochemical study.
Jang KA; Choi JC; Choi JH
J Cutan Pathol; 2001 Oct; 28(9):453-9. PubMed ID: 11553311
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
10. TCR-γ expression in primary cutaneous T-cell lymphomas.
Rodríguez-Pinilla SM; Ortiz-Romero PL; Monsalvez V; Tomás IE; Almagro M; Sevilla A; Camacho G; Longo MI; Pulpillo Á; Diaz-Pérez JA; Montes-Moreno S; Castro Y; Echevarría B; Trébol I; Gonzalez C; Sánchez L; Otín AP; Requena L; Rodríguez-Peralto JL; Cerroni L; Piris MÁ
Am J Surg Pathol; 2013 Mar; 37(3):375-84. PubMed ID: 23348211
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
13. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
14. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma.
Foss HD; Demel G; Anagnostopoulos I; Araujo I; Hummel M; Stein H
Pathobiology; 1997; 65(2):83-90. PubMed ID: 9253032
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
16. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
19. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
20. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
